Search Results - Louwerenburg, J.Hans

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    TCT-251 Abnormal glucose metabolism and adverse event rates 12 months after treatment with contemporary drug-eluting stents: Insights from the BIO-RESORT Silent Diabetes study

    TCT-251 Abnormal glucose metabolism and adverse event rates 12 months after treatment with contemporary drug-eluting stents: Insights from the BIO-RESORT Silent Diabetes study by Kok, Marlies, von Birgelen, Clemens, Zocca, Paolo, Hartmann, Marc, Gert van Houwelingen, K., Stoel, Martin, de Man, Frits, Louwerenburg, J.Hans, Lowik, Marije, Kant, Gert, Doelman, Cees, Linssen, Gerard C.M., van der Heijden, Liefke, Doggen, Carine J.M., Tandjung, Kenneth

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    TCT-549 CHANGE DAPT: clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents

    TCT-549 CHANGE DAPT: clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents by von Birgelen, Clemens, Zocca, Paolo, van der Heijden, Liefke, Kok, Marlies, Stoel, Martin, Hartmann, Marc, de Man, Frits, Louwerenburg, J.Hans, Lowik, Marije, Knottnerus, Iris, Linssen, Gerard C.M., Doggen, Carine J.M., Gert van Houwelingen, K.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: